Glinka; Andrey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glinka; Andrey.The latest application filed is for "cancer treatment by simultaneous targeting energy metabolism and intracellular ph".

Company Profile

4.4.9

Glinka; Andrey - Schriesheim DE
GLINKA; Andrey - Edingen-Neckarhausen DE
Glinka; Andrey - Edingen-Necharhausen DE
- Edingen-Neckarhausen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cancer Treatment by Simultaneous Targeting Energy Metabolism and Intracellular pH App 20190321311 - Glinka; Andrey ; et al.	2019-10-24
Compositions For Diagnosis And Therapy Of Diseases Associated With Aberrant Expression Of Futrins (r-spondins) And/or Wnt App 20190194306 - NIEHRS; Christof ; et al.	2019-06-27
Compositions For diagnosis and Therapy of diseases associated with aberrant expression of Futrins (R-Spondins) and/or Wnt App 20160376349 - Niehrs; Christof ; et al.	2016-12-29
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-spondins) and/or Wnt Grant 9,081,011 - Niehrs , et al. July 14, 2	2015-07-14
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt Grant 8,951,745 - Niehrs , et al. February 10, 2	2015-02-10
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt Grant 8,921,056 - Niehrs , et al. December 30, 2	2014-12-30
Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt Grant 08921056 -	2014-12-30
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140357510 - Niehrs; Christof ; et al.	2014-12-04
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140227713 - Niehrs; Christof ; et al.	2014-08-14
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140186917 - Niehrs; Christof ; et al.	2014-07-03
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20140134703 - Niehrs; Christof ; et al.	2014-05-15
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondins) and/or Wnt App 20130337533 - Niehrs; Christof ; et al.	2013-12-19
Compositions for Diagnosis and Therapy of Diseases Associated with Aberrant Expression of Futrins (R-Spondisn) and/or Wnt App 20070244061 - Niehrs; Christof ; et al.	2007-10-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.